国新健康：11月21日召开董事会会议

Group 1 - The core point of the article is that Guoxin Health (SZ 000503) announced the convening of its 12th eighth board meeting on November 21, 2025, to review documents including a proposal for the internal transfer of equity of its wholly-owned subsidiary [1] - For the first half of 2025, Guoxin Health's revenue composition is entirely from the service industry, accounting for 100.0% [1] - As of the report date, Guoxin Health has a market capitalization of 9.8 billion yuan [1] Group 2 - The article also highlights the significant profit made by the controlling shareholder and his brother from the strategic placement of Dapeng Industrial, with a subscription price of 9 yuan and a first-day listing price of 118 yuan, resulting in a floating profit of 24.92 million yuan in one day [1]